Litigation Details for AbbVie Inc. v. Aurobindo Pharma Limited (D. Del. 2017)
✉ Email this page to a colleague
AbbVie Inc. v. Aurobindo Pharma Limited (D. Del. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-01-13 |
Court | District Court, D. Delaware | Date Terminated | 2017-02-24 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 7,148,359; 7,364,752; 8,025,899; 8,268,349; 8,309,613; 8,377,952; 8,399,015; 8,470,347; 8,691,878 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in AbbVie Inc. v. Aurobindo Pharma Limited
Details for AbbVie Inc. v. Aurobindo Pharma Limited (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2017-02-23 | 7 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,148,359 C1; 7,364,752 C1; 8,025,899… 24 February 2017 1:17-cv-00047 830 Patent None District Court, D. Delaware | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |